Home › NDC Lookup › RxCUI directory › RxCUI 2591502

Daridorexant 25 MG Oral Tablet — RxCUI 2591502

RxNorm drug concept · Semantic clinical drug
RxCUI 2591502 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2591502
Official nameDaridorexant 25 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdaridorexant 25 MG (as daridorexant hydrochloride 27 MG) Oral Tablet
FDA products mapped2
Package NDCs mapped4
Reported Medicaid activity (SDUD)20,970 prescriptions · 35 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Daridorexant: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Quviviq works differently from older sleep medications like benzodiazepines. Instead of generally sedating your brain, it specifically blocks the brain chemicals (called orexins) t...
  • What exactly does Quviviq do — is it like a typical sleeping pill?
  • Take Quviviq within 30 minutes of getting into bed — and only when you have at least 7 full hours before you need to be up. If you take it with or right after a meal, especially a...
  • When exactly should I take it, and does it matter if I eat first?
📖 Read our full Daridorexant guide →

🕸️ Concept Web — How Daridorexant 25 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Daridorexant 25 MG Oral Tablet RxCUI 2591502

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Daridorexant 2591497
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Quviviq 2591503
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Daridorexant Oral Tablet 2591501
    • Daridorexant Oral Product 2591499
    • Daridorexant Pill 2591500
    • Daridorexant Oral Tablet [Quviviq] 2591507
    • Quviviq Oral Product 2591505
    • Quviviq Pill 2591506
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Daridorexant 25 MG SCDC · 2591498
  • Daridorexant Oral Tablet SCDF · 2591501
  • Daridorexant Oral Product SCDG · 2591499
  • Daridorexant Pill SCDG · 2591500

Brand-Name Concepts

  • Daridorexant 25 MG Oral Tablet [Quviviq] SBD · 2591508
  • Daridorexant 25 MG [Quviviq] SBDC · 2591504
  • Daridorexant Oral Tablet [Quviviq] SBDF · 2591507
  • Quviviq Oral Product SBDG · 2591505
  • Quviviq Pill SBDG · 2591506
  • Quviviq BN · 2591503

📦 FDA Products & Package NDCs

2 products · 4 package NDCs
4 package NDCs map to RxCUI 2591502 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
80491-7825-02 1 BLISTER PACK in 1 CARTON (80491-7825-2) / 7 TABLET, FILM... QUVIVIQ Idorsia Pharmaceuticals Ltd 2023-05-01
80491-7825-03 1 BOTTLE in 1 CARTON (80491-7825-3) / 30 TABLET, FILM COATE... QUVIVIQ Idorsia Pharmaceuticals Ltd 2022-04-07
80491-7850-02 1 BLISTER PACK in 1 CARTON (80491-7850-2) / 7 TABLET, FILM... QUVIVIQ Idorsia Pharmaceuticals Ltd 2023-05-01
80491-7850-03 1 BOTTLE in 1 CARTON (80491-7850-3) / 30 TABLET, FILM COATE... QUVIVIQ Idorsia Pharmaceuticals Ltd 2022-04-07
Observed labelers: Idorsia Pharmaceuticals Ltd (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.